LENZ Therapeutics Inc (NAS:LENZ)
$ 5.51 -0.070 (-1.25%) Market Cap: 172.76 Mil Enterprise Value: -84.95 Mil PE Ratio: 0 PB Ratio: 0.70 GF Score: 12/100

LENZ Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 02:50 PM GMT
Release Date Price: $13.68 (+1.41%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LENZ.OQ - Lenz Therapeutics Inc
LENZ Therapeutics Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 02:50PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Okay, well, thanks so much for joining our forty-sixth annual health care conference. I'm Stacy Ku, one of the biotech analysts, and I'm here with my colleague Viz Shaw. We're happy to be hosting Lens, and we have CEO Eve Shimopinnik, and I'm sure joining us soon will be CFO Dan Chevalard and, CCEO Sean Olson. So if we could just, get started with some maybe some opening remarks on the Viz launch, maybe some key learnings since the early October. Product availability.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah, no, happy to do that and thanks for having us
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot